Cargando…

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

SIMPLE SUMMARY: Viruses are being explored as a treatment strategy for cancer by exploiting their ability to infect and kill malignant cells. Viruses also engage the immune system to promote the recognition and clearance of tumors from the body. A major concern with using viruses for therapy is anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burnett, William J., Burnett, David M., Parkman, Gennie, Ramstead, Andrew, Contreras, Nico, Gravley, William, Holmen, Sheri L., Williams, Matthew A., VanBrocklin, Matthew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431599/ https://www.ncbi.nlm.nih.gov/pubmed/34503272 http://dx.doi.org/10.3390/cancers13174462

Ejemplares similares

In vitro visualization and characterization of wild type and mutant IDH homo- and heterodimers using Bimolecular Fluorescence Complementation
por: Robinson, Gemma L., et al.
Publicado: (2016)

HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss
por: Shin, Clifford H., et al.
Publicado: (2017)

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
por: Müller, Louise M. E., et al.
Publicado: (2019)

Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
por: Annels, Nicola E, et al.
Publicado: (2015)

Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021)

Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3
por: Liu, Huitao, et al.
Publicado: (2022)

Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
por: Liu, Huitao, et al.
Publicado: (2021)

SEC coupled with in-line multiple detectors for the characterization of an oncolytic Coxsackievirus
por: Deng, James Z., et al.
Publicado: (2021)

2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus
por: Vorobyev, Pavel O., et al.
Publicado: (2022)

ASA Suppresses PGE(2) in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma
por: Varedi, Amir, et al.
Publicado: (2020)

Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
por: Deng, Haoyu, et al.
Publicado: (2019)

Applications of coxsackievirus A21 in oncology
por: Bradley, Stephen, et al.
Publicado: (2014)

Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
por: Okamura, Koji, et al.
Publicado: (2022)

Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome
por: Sam, Miranda, et al.
Publicado: (2023)

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
por: Hazini, Ahmet, et al.
Publicado: (2021)

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients
por: Pandha, Hardev, et al.
Publicado: (2015)

Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma
por: Yang, H, et al.
Publicado: (2017)

MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer
por: Liu, Huitao, et al.
Publicado: (2020)

MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer
por: Liu, Huitao, et al.
Publicado: (2021)

Appendectomy Mitigates Coxsackievirus B3−Induced Viral Myocarditis
por: Niu, Chengrui, et al.
Publicado: (2023)

Seeing Is Believing: Nuclear Imaging of HIV Persistence
por: Henrich, Timothy J., et al.
Publicado: (2019)

Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
por: Lin, Yanzhen, et al.
Publicado: (2018)

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)
por: Gumbleton, Matthew, et al.
Publicado: (2023)

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma
por: Ray, Abhijit, et al.
Publicado: (2016)

BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases
por: Grigore, Florina, et al.
Publicado: (2020)

PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer
por: Meher, Niranjan, et al.
Publicado: (2023)

Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3
por: Jia, Yang, et al.
Publicado: (2019)

Reverse-Phase Ultra-Performance Chromatography Method for Oncolytic Coxsackievirus Viral Protein Separation and Empty to Full Capsid Quantification
por: Deng, James Z., et al.
Publicado: (2022)

Coxsackievirus Group B3 Has Oncolytic Activity against Colon Cancer through Gasdermin E-Mediated Pyroptosis
por: Zhang, Yejia, et al.
Publicado: (2022)

Mutant IDH1 Promotes Glioma Formation In Vivo
por: Philip, Beatrice, et al.
Publicado: (2018)

Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
por: Shafren, Darren, et al.
Publicado: (2014)

A counterintuitive antibody cocktail disrupts coxsackievirus
por: Zost, Seth J., et al.
Publicado: (2022)

Coxsackievirus A21, Enterovirus 68, and Acute Respiratory Tract Infection, China
por: Xiang, Zichun, et al.
Publicado: (2012)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Etymologia: Coxsackievirus
Publicado: (2012)

COXSACKIEVIRUSES (PICORNAVIRIDAE)
por: Pozzetto, Bruno, et al.
Publicado: (1999)

A cluster of coxsackievirus A21 associated acute respiratory illness: the evidence of efficient transmission of CVA21
por: Zou, Lirong, et al.
Publicado: (2016)

Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer
por: Sakamoto, Akira, et al.
Publicado: (2023)

Case of Gun-Shot Wound of the Shoulder Joint, with Lodgement of the Ball in the Head of the Humerus, Fracture of the Scapula, &c. Wherein Amputation at the Shoulder Joint, under Unfavourable Circumstances, Was Successfully Performed
por: Burnett, William
Publicado: (1818)

How Does Thymus Infection by Coxsackievirus Contribute to the Pathogenesis of Type 1 Diabetes?
por: Michaux, Hélène, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_skknhr2vfp5vsohgni3h7vgkr7